Non-Profit Trusted Source of Non-Commercial Health Information
The Original Voice of the American Academy of Anti-Aging, Preventative, and Regenerative Medicine
logo logo
A4M in the Media Industry News

Tip Sheet: Clinical Reports in Aging Intervention at the Winter 2011 Session of the 19th Annual World Congress on Anti-Aging Medicine

12 years, 8 months ago

15015  0
Posted on Nov 16, 2011, 11 a.m.

Taking place 8-10 December 2011, The Winter 2011 Session of the 19th Annual World Congress on Anti-Aging Medicine features over 80 world renowned experts who present key clinical findings in human aging intervention.  Physicians, scientists, health practitioners, and industry leaders are encouraged to register for this year’s must-attend premier educational program in anti-aging medicine.

Taking place 8-10 December 2011, The Winter 2011 Session of the 19th Annual World Congress on Anti-Aging Medicine is the world’s largest professional educational program outlining practicable medical protocols and biomedical technologies that to aim detect, prevent, and treat aging related disease and optimize the human aging process. Co-sponsored by the American Academy of Anti-Aging Medicine (A4M;, a non-profit medical organization dedicated to educating physicians, scientists, and members of the public on biomedical sciences, breaking technologies, and anti-aging issues, the Winter 2011 Congress will host 3,500+ delegates from over 80 nations who will convene to learn the latest breakthroughs in:

•    Cancer Therapies:  Very Early Disease Detection & Non-Drug/Augmentive Modalities
•    Diabetes, Pre-diabetes, and Metabolic Syndrome: Advanced Assessment & Diagnosis
•    Environmental Radiation Toxic Exposure: Strategies for Defense Against Fallout
•    Stem Cell Therapies for Joint Repair & Rehabilitation
•    Skin De-Aging: Aesthetic Medicine and New Cosmetic Protocols
•    Weight Management: Latest Techniques & Potential Innovative Drug Therapies
•    Theories of Aging & Cellular Rejuvenation

Thursday, December 8
Educational Track:  General Session
Title:  Anti-Aging Survival Protocols
Presenter:  Ronald Klatz, M.D., D.O.
President, American Academy of Anti-Aging Medicine (A4M)
As part of the Congress Opening Remarks, Ronald Klatz, M.D., D.O., presents eye-opening evidence suggesting that while we are on the cusp of significant anti-aging breakthroughs, a number of challenges are poised to destroy this scientific progress.  He offers the audience several practical protocols that formulate an anti-aging survival program to address modern-day life-robbing health challenges.

Thursday, December 8
Educational Track:  General Session
Title:  Keynote Address – The Osteopathic Medical Profession
Presenter:  Martin S. Levine, D.O., MPH, FACOFP
President, American Osteopathic Association (AOA)
Martin S. Levine, D.O., MPH, FACOFP provides information about the demographics of the osteopathic medical profession, in relation to the AOA’s role in setting health policy.  With the A4M and AOA sharing similar preventative medicine goals, Dr. Levine explains how prevention and wellness serve as the foundation for the training and education that osteopathic physicians (DOs) receive.

Friday, December 9
Educational Track:  General Session
Title:  Featured Lecture – Testosterone & Prostate Cancer: A Conceptual Revolution
Presenter:  Abraham Morgentaler, M.D.
Associate Clinical Professor of Surgery, Harvard Medical School; Author, “Testosterone for Life”
Abraham Morgentaler, M.D. reassesses the role of testosterone – offering evidence to counter the notion that the hormone is a prime factor in prostate cancer growth. He shares clinical evidence that indicatives that testosterone therapy appears to be safe with regard to prostate cancer, and may even exert therapeutic benefit in specific cases of the disease. 

Friday, December 9
Educational Track:  General Session
Title:  Restricted Ketogenic Diet as Treatment for Malignant Tumors
Presenter:  Joseph C. Maroon, M.D.
Professor and Vice Chairman of Neurological Surgery & Heindl Scholar in Neuroscience, University of Pittsburgh School of Medicine; Team Physician, Pittsburgh Steelers
Malignant brain cancer (glioblastoma multiforme GBM) is a catastrophic disease with a mean survival of 12-18 months, and the number of cases of this deadly cancer are on the rise. Joseph C.  Maroon, M.D. submits that malignancies of most kinds are a glucose/glutamine dependant entity, and that a calorie restricted ketogenic diet (RKGD) involving a ratio of 4:1 fat to protein/CHO may be considered as the initial treatment of brain cancer after diagnosis.  He shares clinical evidence that shows that RKGD combined with drugs targeting glucose and glutamine reduction may provide a rational strategy for the long-term management of most malignant brain and other cancers. 

Friday, December 9
Educational Track:  Breakout Track 1
Title:  Aging-Reversing Properties of Thyrotropin Hormone
Presenter:  Walter Pierpaoli, M.D., Ph.D.
Director, Jean Choay Institute for Biomedical Research in Neuroimmodulation; Author, “The Melatonin Miracle”
One of the world’s foremost researchers in melatonin and related neuropeptides, Walter Pierpaoli, M.D., Ph.D. expands his research scope to explore the hormonal basis of neurodegenerative diseases. His presentation discusses clinical perspectives to impaired brain and nerve functioning – manifesting as poor memory, cognition, attention span, learning ability and physical incompetence.

Friday, December 9
Educational Track:  Breakout Track 1
Title:  Platelet Rich Plasma (PRP) and Stem Cell Injections in an Office Setting
Presenter:  Joseph Purita, M.D.
Director, The Institute of Regenerative and Molecular Orthopedics
Focusing on the clinical application of stem cells for orthopedic injuries, Joseph Purita, M.D. reviews the compounds key in the production of  growth factors that allow stem cells to migrate to areas of injury.  As well, he presents case studies that document the use of Platelet Rich Plasma, in conjunction with Bone Marrow Stem Cells (BMAC) and Adipose Stem Cells (SVF) and fat grafts, to successfully treat a variety of orthopedic conditions in an office setting. Dr. Purita shares the results of 3,800 cases performed at The Institute of Regenerative and Molecular Orthopedics, involving both PRP and bone marrow aspirate concentration injections (BMAC). 

Friday, December 9
Educational Track:  Breakout Track 3
Title:  Prevention of Age-Associated Disease by Optimizing the Micronutrient Intake: Triage Theory
Presenter:  Bruce N. Ames, Ph.D.
Professor Emeritus, University of  California/Berkeley; Senior Scientist, Children’s Hospital Oakland Research Institute
Bruce N. Ames, Ph.D. is author of the Triage Theory, which submits that micronutrients (approximately 40 essential vitamins, minerals, fatty acids and amino acids) are substances essential to proper metabolic function and thus both short-term survival and long-term health. Triage theory predicts that the consequence of moderate shortages of even a single micronutrient, though insufficient to cause overt clinical symptoms, will impair functions essential for long-term health. This impairment will result in insidious damage (e.g. increased DNA damage) that, over time, leads to the acceleration of age-associated diseases (e.g. increased cancer). As people with modest deficiencies have no overt clinical symptoms, there has been little incentive to correct these deficiencies, though this could change if it can be shown that they are resulting in biochemical changes, e.g. chromosome breaks, that are markers of increased risk of age-related diseases, e.g. cancer. The considerable experimental and theoretical support for the triage idea will be discussed as will a strategy for determining the optimum level of each micronutrient in humans.

Saturday, December 10

Educational Track:  Breakout Track 1
Title:  The Toxic Triangle: Diabesity, Glycation, and Environmental Toxins
Presenter:  Frederic Vagnini, M.D.
Medical Director, Heart, Diabetes & Weight Loss Centers of New York
Frederic Vagnini, M.D. presents The Toxic Triangle, a theory that offers preventative strategies to counter the array of health complications associated with degenerative disease. The first component of the Toxic Triangle, diabesity – the combination of obesity, diabetes and incident cardiovascular disease, poses a significant danger to individual patients and poses as an emerging public health issue.  Glycation, the second component of the Toxic Triangle, involves cellar damage caused by glucose and other sugars as the result of Advanced Glycation End products (AGEs), and is linked to accelerated oxidative damage, inflammation, organ damage and progressive atherothrombosis.  Exposure to environmental toxins, the third element of the Toxic Triangle, can lead to neurological dysfunction, enzyme and metabolic disorders, obesity, depressed immunity, endocrine dysfunction and cancer.  For each of the three aspects of the Toxic Triangle, Dr. Vagnini presents practical therapeutic guidelines to intervene in the effects and thereby effectively retard the onslaught of degenerative aging-related diseases.

WorldHealth Videos